These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
150 related articles for article (PubMed ID: 2117385)
1. Effect of glyburide on beta cell responsiveness to glucose in non-insulin-dependent diabetes mellitus. O'Meara NM; Shapiro ET; Van Cauter E; Polonsky KS Am J Med; 1990 Aug; 89(2A):11S-16S; discussion 51S-53S. PubMed ID: 2117385 [TBL] [Abstract][Full Text] [Related]
2. Glyburide enhances the responsiveness of the beta-cell to glucose but does not correct the abnormal patterns of insulin secretion in noninsulin-dependent diabetes mellitus. Shapiro ET; Van Cauter E; Tillil H; Given BD; Hirsch L; Beebe C; Rubenstein AH; Polonsky KS J Clin Endocrinol Metab; 1989 Sep; 69(3):571-6. PubMed ID: 2503533 [TBL] [Abstract][Full Text] [Related]
3. The effect of glimepiride on pancreatic beta-cell function under hyperglycaemic clamp and hyperinsulinaemic, euglycaemic clamp conditions in non-insulin-dependent diabetes mellitus. Clark HE; Matthews DR Horm Metab Res; 1996 Sep; 28(9):445-50. PubMed ID: 8911981 [TBL] [Abstract][Full Text] [Related]
4. Effects of glyburide on in vivo insulin-mediated glucose disposal. Simonson DC Am J Med; 1990 Aug; 89(2A):44S-50S; discussion 51S-53S. PubMed ID: 2117389 [TBL] [Abstract][Full Text] [Related]
5. Twenty-four-hour profiles and pulsatile patterns of insulin secretion in normal and obese subjects. Polonsky KS; Given BD; Van Cauter E J Clin Invest; 1988 Feb; 81(2):442-8. PubMed ID: 3276730 [TBL] [Abstract][Full Text] [Related]
6. Different effects of glyburide and glipizide on insulin secretion and hepatic glucose production in normal and NIDDM subjects. Groop L; Luzi L; Melander A; Groop PH; Ratheiser K; Simonson DC; DeFronzo RA Diabetes; 1987 Nov; 36(11):1320-8. PubMed ID: 3117609 [TBL] [Abstract][Full Text] [Related]
7. Fasting plus prandial insulin supplements improve insulin secretory ability in NIDDM subjects. Kawamori R; Bando K; Yamasaki Y; Kubota M; Watarai T; Iwama N; Shichiri M; Kamada T Diabetes Care; 1989; 12(10):680-5. PubMed ID: 2515048 [TBL] [Abstract][Full Text] [Related]
8. Effect of glyburide on hepatic glucose metabolism. McGuinness OP; discussion 51S-53S ; Cherrington AD Am J Med; 1990 Aug; 89(2A):26S-37S. PubMed ID: 2117387 [TBL] [Abstract][Full Text] [Related]
9. A novel enhancer of insulinotrophic action by high glucose (JTT-608) stimulates insulin secretion from pancreatic beta-cells via a new cellular mechanism. Itabashi N; Okada K; Muto S; Fujita N; Ohta T; Miyazaki Ji ; Asano Y; Saito T J Pharmacol Exp Ther; 2001 Jun; 297(3):953-60. PubMed ID: 11356916 [TBL] [Abstract][Full Text] [Related]
10. Effects of weight loss and reduced hyperglycemia on the kinetics of insulin secretion in obese non-insulin dependent diabetes mellitus. Gumbiner B; Polonsky KS; Beltz WF; Griver K; Wallace P; Brechtel G; Henry RR J Clin Endocrinol Metab; 1990 Jun; 70(6):1594-602. PubMed ID: 2189885 [TBL] [Abstract][Full Text] [Related]
11. Lilly Lecture 1994. The beta-cell in diabetes: from molecular genetics to clinical research. Polonsky KS Diabetes; 1995 Jun; 44(6):705-17. PubMed ID: 7789637 [TBL] [Abstract][Full Text] [Related]
12. The effect of glyburide on beta-cell sensitivity to glucose-dependent insulinotropic polypeptide. Meneilly GS; Bryer-Ash M; Elahi D Diabetes Care; 1993 Jan; 16(1):110-4. PubMed ID: 8422763 [TBL] [Abstract][Full Text] [Related]
14. Interaction of sulfonylureas with pancreatic beta-cells. A study with glyburide. Gorus FK; Schuit FC; In't Veld PA; Gepts W; Pipeleers DG Diabetes; 1988 Aug; 37(8):1090-5. PubMed ID: 2839387 [TBL] [Abstract][Full Text] [Related]
15. Abnormal patterns of insulin secretion in non-insulin-dependent diabetes mellitus. Polonsky KS; Given BD; Hirsch LJ; Tillil H; Shapiro ET; Beebe C; Frank BH; Galloway JA; Van Cauter E N Engl J Med; 1988 May; 318(19):1231-9. PubMed ID: 3283554 [TBL] [Abstract][Full Text] [Related]
16. The influence of GLP-1 on glucose-stimulated insulin secretion: effects on beta-cell sensitivity in type 2 and nondiabetic subjects. Kjems LL; Holst JJ; Vølund A; Madsbad S Diabetes; 2003 Feb; 52(2):380-6. PubMed ID: 12540611 [TBL] [Abstract][Full Text] [Related]
17. Glyburide and tolbutamide induce desensitization of insulin release in rat pancreatic islets by different mechanisms. Rabuazzo AM; Buscema M; Vinci C; Caltabiano V; Vetri M; Forte F; Vigneri R; Purrello F Endocrinology; 1992 Oct; 131(4):1815-20. PubMed ID: 1396327 [TBL] [Abstract][Full Text] [Related]
18. Stimulation of insulin release by repaglinide and glibenclamide involves both common and distinct processes. Fuhlendorff J; Rorsman P; Kofod H; Brand CL; Rolin B; MacKay P; Shymko R; Carr RD Diabetes; 1998 Mar; 47(3):345-51. PubMed ID: 9519738 [TBL] [Abstract][Full Text] [Related]
19. Glyburide decreases insulin requirement, increases beta-cell response to mixed meal, and does not affect insulin sensitivity: effects of short- and long-term combined treatment in secondary failure to sulfonylurea. Gutniak M; Karlander SG; Efendić S Diabetes Care; 1987; 10(5):545-54. PubMed ID: 2890501 [TBL] [Abstract][Full Text] [Related]
20. Evaluating insulin secretagogues in a humanized mouse model with functional human islets. Luo J; Nguyen K; Chen M; Tran T; Hao J; Tian B; Rulifson IC; Zhang Y; Tian L; Zhang Y; Lopez E; Lin DC; Wang Y; Ma Z; Houze J; Guo Z Metabolism; 2013 Jan; 62(1):90-9. PubMed ID: 22982177 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]